Gholamreza Roshandel1, Shahryar Semnani1, Abdolreza Fazel2, Mohammadreza Honarvar3, MohammadHossein Taziki4, SeyedMehdi Sedaghat3, Nafiseh Abdolahi5, Mohammad Ashaari6, Mohammad Poorabbasi7, Susan Hasanpour1, SeyedAhmad Hosseini8, SeyedMohsen Mansuri9, Ataollah Jahangirrad10, Sima Besharat1, Abbas Moghaddami3, Honeyehsadat Mirkarimi1, Faezeh Salamat1, Fatemeh Ghasemi-Kebria1, Nastaran Jafari1, Nesa Shokoohifar1, Masoomeh Gholami7, Alireza Sadjadi11, Hossein Poustchi11, Freddie Bray12, Reza Malekzadeh13. 1. Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences, Gorgan, Iran. 2. Hyrcania Cancer Research Center, Golestan University of Medical Sciences, Gorgan, Iran. 3. Deputy of Public Health, Golestan University of Medical Sciences, Gorgan, Iran. 4. Hyrcania Cancer Research Center, Golestan University of Medical Sciences, Gorgan, Iran; Deputy of Research and Technology, Golestan University of Medical Sciences, Gorgan, Iran. 5. Rheumatology Research Center, Golestan University of Medical Sciences, Gorgan, Iran. 6. Department of Pathology, Sayyad Shirazi Hospital, Golestan University of Medical Sciences, Gorgan, Iran. 7. Death Registry Unit, Deputy of Public Health, Golestan University of Medical Sciences, Gorgan, Iran. 8. Deputy of Treatment, Golestan University of Medical Sciences, Gorgan, Iran. 9. Statistics and Information Technology Office, Golestan University of Medical Sciences, Gorgan, Iran. 10. Shafa Radiotherapy Center, 5 Azar Hospital, Gorgan, Iran. 11. Digestive Oncology Research Center, Digestive Disease Research Institute, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran. 12. Cancer Surveillance Section, International Agency for Research on Cancer, Lyon, France. 13. Digestive Oncology Research Center, Digestive Disease Research Institute, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: malek@ams.ac.ir.
Abstract
INTRODUCTION: The Golestan population-based cancer registry (GPCR) was established in Golestan province, Northern Iran, within the Asian belt with predominance of upper-gastrointestinal cancers. We aimed to present the experiences of the registry in a resource-limited setting over the 10 years since its inception (2004-2013). METHODS: The GPCR was established as a research project to enable sustainable funding. A clear plan was developed for use of the GPCR data. New primary cancers were registered based on international standards, indices of data quality were routinely assessed and age-standardized incidence rates (ASR) per 100,000 person-years calculated using IARC's CanReg-5 software. RESULTS: Overall, 19807 new cancer cases were registered during the study period, an average of 1981 cases per annum, with overall ASR of 175.0 and 142.4 in males and females, respectively. The GPCR data suggested gastrointestinal and breast cancers as the most common malignancies in Golestan province. We observed increasing incidence rates of breast and colorectal cancers but declining trends of esophageal cancer. Overall, indices of data quality were within acceptable ranges. CONCLUSIONS: The GPCR data have been included in IARC's Cancer Incidence in Five Continents series, were used in 21 research projects, and published as 30 research papers. The key ingredients for the successful establishment and maintenance of the GPCR included sustainable sources of funding, a clear action plan for the use of data as well as stakeholder cooperation across all areas of the registration. The GPCR may be considered as a model for planning population-based cancer registries in lesser-resourced settings.
INTRODUCTION: The Golestan population-based cancer registry (GPCR) was established in Golestan province, Northern Iran, within the Asian belt with predominance of upper-gastrointestinal cancers. We aimed to present the experiences of the registry in a resource-limited setting over the 10 years since its inception (2004-2013). METHODS: The GPCR was established as a research project to enable sustainable funding. A clear plan was developed for use of the GPCR data. New primary cancers were registered based on international standards, indices of data quality were routinely assessed and age-standardized incidence rates (ASR) per 100,000 person-years calculated using IARC's CanReg-5 software. RESULTS: Overall, 19807 new cancer cases were registered during the study period, an average of 1981 cases per annum, with overall ASR of 175.0 and 142.4 in males and females, respectively. The GPCR data suggested gastrointestinal and breast cancers as the most common malignancies in Golestan province. We observed increasing incidence rates of breast and colorectal cancers but declining trends of esophageal cancer. Overall, indices of data quality were within acceptable ranges. CONCLUSIONS: The GPCR data have been included in IARC's Cancer Incidence in Five Continents series, were used in 21 research projects, and published as 30 research papers. The key ingredients for the successful establishment and maintenance of the GPCR included sustainable sources of funding, a clear action plan for the use of data as well as stakeholder cooperation across all areas of the registration. The GPCR may be considered as a model for planning population-based cancer registries in lesser-resourced settings.
Authors: Arash Etemadi; Ian D Buller; Maryam Hashemian; Gholamreza Roshandel; Hossein Poustchi; Maria Morel Espinosa; Benjamin C Blount; Christine M Pfeiffer; Behnam Keshavarzi; Abigail R Flory; Siavosh Nasseri-Moghaddam; Sanford M Dawsey; Neal D Freedman; Christian C Abnet; Reza Malekzadeh; Mary H Ward Journal: Environ Res Date: 2022-07-19 Impact factor: 8.431
Authors: Nima Daneshi; Mohammad Fararouei; Mohammad Mohammadianpanah; Mohammad Zare-Bandamiri; Somayeh Parvin; Mostafa Dianatinasab Journal: J Cancer Epidemiol Date: 2018-06-03